Last week, I warned you about the dangers of taking ACE inhibitor and ARB drugs to lower your blood pressure. It turns out, people who take these drugs may be more susceptible to—and have a harder time getting over—the coronavirus.
And, now, cholesterol-lowering statin drugs have also come under fire.
Specifically, one whistleblower has pointed out that these drugs may impair the body’s ability to fight off coronavirus and other infectious diseases—based on some very damning evidence.
Of course, these drugs are taken by millions of unsuspecting people around the world. And as the coronavirus continues to spread, it’s critical that we get answers.
In a moment, I’ll tell you everything we know about this new statin-coronavirus link. But first, let’s back up…
Statins have a laundry list of other known side effects
Even before the coronavirus outbreak, I strongly urged you against ever taking a cholesterol-lowering statin drug.
Yes, these drugs do artificially lower your cholesterol. But, as I’ve reported many times before, every cell in your body needs cholesterol to thrive. In fact, it’s an essential building block for molecules, cells, and tissues. And it’s also critical for the production of many hormones, including estrogen, testosterone, and cortisone, and the adrenal cortical hormones.
Plus, by artificially lowering cholesterol, statin drugs cause a cascade of problems…starting with immediate, crippling pain in the muscles. (This acute side effect is more serious than it sounds, as the heart itself is a muscle!)
Of course, big pharma tries to claim the muscle pain is due to a “rare” genetic disorder. But that explanation doesn’t pass muster, as up to one-third of people who take statins experience muscle pain…even after just one or two days of treatment. (Fortunately, the crippling pain typically goes away a day or two after stopping the drugs.)
However, for those people “lucky” enough to be able to tolerate them for longer, these toxic drugs can cause a host of chronic medical problems as well. In fact, the list of chronic diseases linked to these drugs reads like the International Classification of Diseases (ICD). It includes:
- Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease
- Heart disease
- Liver damage
- Nerve damage
- Type II Diabetes
And, now, it appears we must add yet another dangerous side effect to this long, sad list…
Impairment of your immune system.
And that point brings us back to the unsettling, new research…
Statins impair your body’s ability to fight off infections
The new concerns about statin drugs stem from a brand-new report published in the prestigious medical journal The Lancet, which found that COVID-19 patients had “significantly” lower cholesterol levels than healthy controls. The researchers theorized that low cholesterol may impair immune response, making it harder for patients to get over infections of all kinds…including COVID-19.
Then, in response to this new research, an independent Swedish researcher went a step further…
In a letter published to The BMJ online, the Swedish researcher urged doctors to immediately take their COVID-19 patients off cholesterol-lowering statin drugs because they may “worsen” outcomes.
To support his point, the Swede cited three previously published studies that show low cholesterol makes people more susceptible to infection…
Cholesterol helps the body block and neutralize bacterial and viral infections
In the first study, human LDL (so-called “bad”) cholesterol was found to inactivate 90 percent of deadly toxins produced by the “superbug” staphylococcus aureus. Plus, rats infected with deadly bacterial toxins survived if they were injected with human LDL cholesterol.
In the second study, patients with lower total cholesterol had higher death rates from fatal respiratory and GI conditions, most of which were infections.
And in a third study of more than 120,000 adults, there was a strong connection between low cholesterol at the beginning of the study and hospitalization due to infections later in life.
In his comments, the Swedish researcher said, “it’s a little-known fact [that low cholesterol is linked to greater infection risk] but has been documented in many ways by more than a dozen research groups.”
Which leaves me wondering…why is it a little-known fact? And why haven’t we heard about this problem with statins before?
No one should take statins, ever, for anything
As I mentioned at the beginning of this Dispatch, the bottom line is that no one should take statins, ever, for anything.
But if your doctor, for some reason, still has you on one of these disastrous drugs, it’s time to ask questions. If they can’t make a convincing, evidence-backed case as to why you, personally and specifically, need them, maybe you start saying “no” to statins.
Because unlike going off an ACE inhibitor or ARB “cold turkey,” which could possibly be dangerous, in some cases, you can just stop taking a statin drug.
That’s because statin drugs “work” by disrupting your body’s own natural cholesterol production. So when you stop taking them, your body can go back to operating the way it’s meant to.
Which explains why most people find they start to feel a lot better…almost overnight…after stopping a statin regimen.
In addition to talking to your doctor about getting off statin drugs ASAP, I also suggest you start taking some practical steps RIGHT NOW to boost your immunity, including supplementing with 10,000 IU of vitamin D daily. (You can learn more about my top immune health recommendations in my Pandemic Protection Playbook: How to become “immune ready” in every season. To gain access this essential guide, click here now!)
And lastly—there are other drugs that work well for high blood pressure, heart disease, and Type II diabetes (and they don’t impair immune system health or damage the lungs). For guidance about how to support your heart and lung health without resorting to the harmful drugs, refer to my two online learning protocols: my Heart Attack Prevention and Repair Protocol and Breathe Better Lung Health Protocol.
“Low Serum Cholesterol level among patients with COVID-19 infection in Wenzhou, China.” The Lancet, 2/21/20. (ssrn.com/abstract=3544826)
“Rapid Response to: Covid-19: a remote assessment in primary care.” BMJ 2020; 368:m1182. doi.org/10.1136/bmj.m1182
“Binding and Partial Inactivation of Staphylococcus aureus a-Toxin by Human Plasma Low Density Lipoprotein.” The Journal of Biological Chemistry, 1983. 258(9): 5899-5904.